HIKMA Pharmaceuticals PLC — Director's Dealing 2018

Feb 8, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3429E

Hikma Pharmaceuticals Plc

08 February 2018

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Chairman and Chief Executive Officer / PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Release of a pledge by Darhold Limited over 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc.  The Chairman and Chief Executive is a director of and shareholder in Darhold Limited with an equity interest of 21.67%.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 2,000,000
d)	Aggregated information	Aggregated volume: 2,000,000 Price: £0.00p
e)	Date of the transaction	7 December 2017
f)	Place of the transaction	Amman

Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman / PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Release of a pledge by Darhold Limited over 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc.  The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.92%.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 2,000,000
d)	Aggregated information	Aggregated volume: 2,000,000 Price: £0.00p
e)	Date of the transaction	7 December 2017
f)	Place of the transaction	Amman

Mohammed 'Ali' Al-Husry

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mohammed 'Ali' Al-Husry
2	Reason for the notification
a)	Position/status	Non-Executive Director/ PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Release of a pledge by Darhold Limited over 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc.  The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.01%.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 2,000,000
d)	Aggregated information	Aggregated volume: 2,000,000 Price: £0.00p
e)	Date of the transaction	7 December 2017
f)	Place of the transaction	Amman

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBDGDDIXGBGII